Preview

Obstetrics, Gynecology and Reproduction

Advanced search

Significance of detecting antiphospholipid antibodies and genetic mutations of hemostasis for in vitro fertilization

https://doi.org/10.17749/2313-7347.2019.13.3.240-244

Full Text:

Abstract

A case of pregravid preparation is described for an in vitro fertilization (IVF) attempt in a woman after four previous IVF failures. Considering her personal and family aggravated medical history, including the family anamnesis, the patient underwent a hemostasis examination including a test for genetic mutations. A high titer of antiphospholipid antibodies of various types and multigene mutations associated with thrombophilia were found. For the treatment of acquired and inherited thrombophilia, vitamin-antioxidant and intravenous immunoglobulin therapy was initiated as well as a course of hirudotherapy. After starting of pregnancy throughout the gestation period, anticoagulant therapy by low molecular weight heparins, antiplatelet, and antioxidant therapy was carried out; in parallel, D-dimer, thrombin-antithrombin and platelet aggregation markers of thrombophilia were monitored. Pregnancy successfully ended by childbirth at 39 weeks.

About the Author

V. I. Linnikov
Saint Paul German Medical and Diagnostic Center
Ukraine

Valery I. Linnikov – MD, PhD, Professor

68/2 Novoselskogo St., Odessa 65023



References

1. Makatsariya A.D., Akinshina S.V., Bitsadze V.O. et al. Thrombophilia and thromboembolic complications associated with use of assistive reproductive technologies. [Trombofiliya i tromboembolicheskie oslozhneniya, svyazannye s ispol'zovaniem vspomogatel'nyh reproduktivnyh tekhnologij]. Akusherstvo, ginekologiya i reprodukciya. 2014;8(2):89–96. (In Russ.).

2. Makatsariya A.D., Bitsadze V.O., Khizroeva D.Kh. et al. Pathogenetic significance of antiphospholipid antibodies. [Patogeneticheskoe znachenie antifosfolipidnyh antitel]. Prakticheskaya medicina. 2012;(5):9–21. (In Russ.).

3. Simone N., Meroni P.L., de Papa N. et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β 2 -glycoprotein I. Arthritis Rheum. 2000;43(1):140–50. DOI: 10.1002/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P.

4. Franklin R.D., Kutten W.H. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum Reprod. 2002;17(11):2981–5. DOI: 10.1093/humrep/17.11.2981.

5. Carp H.J., Sapir T., Shoenfeld Y. Intravenous immunoglobulin and recurrent pregnancy loss. Clin Rev Allergy Immunol. 2005;29(3):327–32. DOI: 10.1385/CRIAI:29:3:327.

6. Linnikov V.I. Clinical and laboratory indicators of pregnant women with antiphospholipid syndrome in complex therapy with using of intravenous immunoglobulin. [Kliniko-laboratornye pokazateli beremennyh s antifosfolipidnym sindromom pri kompleksnoj terapii s primeneniem vnutrivennogo immunoglobulina]. Akusherstvo, ginekologiya i reprodukciya. 2015;9(3):11–6. (In Russ.). DOI: 10.17749/2070-4968.2015.9.3.011-016.

7. Chen M.L., Sapir R.M., Porter T.F. Regulatory T-cells suppress tumorspecific CD8 T-cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci USA. 2005;102(2):419–24. DOI: 10.1073/pnas.0408197102.

8. Makatsariya A.D., Bitsadze V.O., Baimuradova S.M. et al. Antiphospholipid syndrome – immune thrombophilia in obstetrics and gynecology. Ed. A.D. Makatsaria. [Antifosfolipidnyj sindrom – immunnaya trombofiliya v akusherstve i ginekologii. Pod red. A.D. Makacariya]. Moskva: Triada-X, 2007. 456 s. (In Russ.).

9. Dolgushina N.V. Management of pregnancy and childbirth in patients with genital herpes and antiphospholipid syndrome. [Vedenie beremennosti rodov u bol'nyh genital'nym gerpesom i antifosfolipidnym sindromom]. Avtoref. dis. kand. med. nauk. Moskva, 2000. 25 s. (In Russ.).

10. Prober C.G. Epidemiology and transmission of herpes simplex virus in pregnancy and the neonate. Herpes. 1995;2(1):13–5.

11. Linnikov V.I. Diagnosis, principles of treatment and prevention of thrombophilic conditions caused by the primary antiphospholipid syndrome in pregnant women, parturient women and puerperas. [Diagnostika, principy lecheniya i profilaktiki trombofilicheskih sostoyanij, obuslovlennyh pervichnym antifosfolipidnym sindromom u beremennyh, rozhenic i rodil'nic]. Avtoref. dis. dokt. med. nauk. Odessa, 2006. 36 s. (In Russ.).


For citation:


Linnikov V.I. Significance of detecting antiphospholipid antibodies and genetic mutations of hemostasis for in vitro fertilization. Obstetrics, Gynecology and Reproduction. 2019;13(3):240-244. (In Russ.) https://doi.org/10.17749/2313-7347.2019.13.3.240-244

Views: 29


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)